TruAlt Bioenergy Limited company name has approved the slump sale of its Unit 5, located in Muttalageri Village, Badami Taluka, Karnataka, to Onkar Agro Sugars & Energy Private Limited for an aggregate consideration of ₹171 crore. The Board of Directors ratified the transaction during its meeting on August 4, 2026, marking a strategic move to divest a non-core asset that currently generates no revenue but carries significant debt obligations.

The primary driver behind the divestment is the reduction of financial liabilities associated with the unit. Unit 5 holds an outstanding term loan of approximately ₹135 crore from the Indian Renewable Energy Development Agency Limited (IREDA). Management stated that the interest costs on this loan have adversely impacted profitability and cash flows. By selling the undertaking as a going concern, including land, buildings, plant, and machinery, the company intends to utilize the proceeds primarily to repay this debt, with the remaining balance deployed toward core business operations and high-growth opportunities.

Transaction Details

The sale is structured as a slump sale under Section 2(42A) of the Income Tax Act, though specific tax implications were not detailed in the filing. The transaction is subject to customary closing adjustments, fulfillment of conditions precedent, and receipt of necessary statutory and regulatory approvals. An Memorandum of Understanding (MOU) was executed on August 4, 2026, with definitive agreements to follow after due diligence.

The buyer, Onkar Agro Sugars & Energy Private Limited, is not related to the promoters or group companies of TruAlt Bioenergy, confirming the transaction is at arm's length. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Financial Impact and Strategic Rationale

Unit 5 contributed nil turnover or revenue during the financial year ended March 31, 2026. However, its carrying value of net assets stood at ₹159.32 crore, representing 10.53% of the company’s total net worth as of March 31, 2026. The divestment allows the company to shed a liability-heavy asset that was draining resources without contributing to top-line growth.

What the Numbers Show

The disparity between the sale consideration of ₹171 crore and the outstanding debt of ₹135 crore suggests a potential immediate improvement in net cash position, assuming no other significant liabilities are attached to the unit. By removing ₹135 crore of debt from its books, the company is expected to see a reduction in finance costs, which should positively impact future earnings before interest and taxes (EBIT) and overall cash flow generation. This aligns with management’s stated goal of enhancing operational efficiency and capital allocation.

The company expects to complete the disposal by November 4, 2026. Further details regarding the definitive agreement and final consideration adjustments will be disclosed upon execution. The information is also available on the company’s website.

TruAlt Bioenergy confirmed its robust first-quarter performance by publishing its unaudited financial results for the quarter ended June 30, 2026 (Q1FY27), in Financial Express and Vishwavani on July 29, 2026. The disclosure follows the Board of Directors' approval of the results on July 28, 2026, which revealed a consolidated net profit of ₹59.27 crore — a 12.5x increase from ₹4.73 crore in the corresponding period of FY26. This publication ensures regulatory compliance and broadens investor access to the company’s significant turnaround, driven by its dual-feed ethanol platform integration.

The results were reviewed by the Audit Committee and subjected to a limited review by statutory auditors N. M. Rajji & Co., who issued an unmodified report. The filing was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the financial results is also available on the company’s website at www.trualtbioenergy.com and the stock exchanges’ portals.

Financial Highlights

The table below summarises key consolidated financial metrics for the quarter:

Consolidated total income stood at ₹641.41 crore, up from ₹326.63 crore in Q1FY26. Other income declined to ₹145.25 lakh from ₹227.42 lakh in the prior year, but this was more than offset by the jump in operating revenue. Total expenses increased to ₹5,629.62 lakh from ₹3,208.34 lakh, primarily due to higher cost of materials consumed (₹3,335.23 lakh vs ₹734.91 lakh) and changes in inventories of finished goods (₹476.88 lakh vs ₹1,237.22 lakh).

Operational & Strategic Progress

The company's transition to a dual-feed platform allows it to utilise both sugar derivatives and grains unfit for human consumption, enabling near year-round production. Current capacity utilisation stands at 60.57%, providing significant headroom for growth without substantial incremental capital expenditure. Approximately 1,300 KLPD (65%) of the installed capacity now operates on dual-feed technology.

Strategic initiatives across other business verticals also advanced:

• Compressed Biogas (CBG): Construction continues across four CBG plants under a joint venture with Sumitomo Corporation. Preparatory activities are progressing for six additional CBG plants under a partnership with GAIL (India) Limited.
• Sustainable Aviation Fuel (SAF): The proposed 100 million litres per annum SAF project in Andhra Pradesh is advancing, supported by a ₹150 crore grant under the PM JI-VAN Yojana.
• Fuel Retailing: TruAlt operates seven retail fuel outlets. Due to geopolitical tensions in West Asia and crude oil volatility, the company adopted a cautious approach to expansion, prioritising capital discipline over rapid rollout.

What the Numbers Show

The dramatic improvement in net profit is largely attributable to the scale-up in ethanol production and sales, which drove revenue growth significantly ahead of expense increases. The expansion in EBITDA margin to 21.18% from 13.67% underscores the meaningful improvement in operating profitability. While cost of materials consumed rose sharply, the contribution margin in the ethanol segment expanded substantially, indicating better pricing power or operational leverage. Grain-based operations delivering approximately 6% higher profitability than sugar-based production highlights the value of feedstock diversification. However, the pending updation of the fixed assets register for Unit 4, as highlighted in the auditor's emphasis of matter, suggests that capitalisation processes for recent feedstock conversion investments are still being finalised, which may impact future depreciation charges.

Standalone results mirrored the consolidated trend, with net profit reaching ₹550.06 lakh against ₹2.57 lakh in Q1FY25. Standalone revenue from operations was ₹6,159.22 lakh, up from ₹2,939.35 lakh. Earnings per share on a standalone basis were ₹6.41, compared to ₹0.00 in the previous year. No dividend was declared for the quarter.